Skip to content

Ketamine: all studies

Page 129 of 449: studies 1,281 to 1,290 of 4,486, newest first. Back to the ketamine overview

Research

Intravenous ketamine for emergency department treatment of suicidal ideation in a paediatric population: protocol for a double-blind, randomised, placebo-controlled, parallel-arm pilot trial (KSI study).

BMJ Open July 5, 2024 Michael Schlegelmilch, Amy C. Plint, Nicholas Barrowman et al. 2 citations

Suicidal ideation (SI) is a common and severe cause of morbidity in adolescents. Patients frequently present to the emergency department (ED) for care, yet there is no acute therapeutic intervention for SI. A single dose of intravenous ketamine has demonstrated efficacy in rapidly reducing SI in adults; however, ketamine has not been studied in paediatrics. We aim to determine the feasibility...

DOI: 10.1136/bmjopen-2024-085681 (opens in new tab) Full text (opens in new tab) Emergency service, hospital Paediatrics Suicide & self-harm Pediatric mental health +4

A Comparative Study on the Effectiveness of Electroconvulsive Therapy and Ketamine in Persons Suffering from Treatment-resistant Depressive Disorder

Indian Journal of Psychiatric Nursing July 1, 2024 V. Ramasubramanian, S. Mathumathi, G. Thirumalaisamy et al.

ABSTRACT Depression is a common illness that affects about 3.8% of the population worldwide. Patients with major depression respond to antidepressant treatment, but 10%–20% of them do not improve or show a partial response. It is coupled with functional impairment, poor quality of life, suicide ideation and attempts, self-injurious behavior, and a high relapse rate. Treatment-resistant...

The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats.

Psychopharmacology July 1, 2024 Dilan Gokalp, Gunes Unal

Ketamine produces dissociative, psychomimetic, anxiolytic, antidepressant, and anesthetic effects in a dose dependent manner. It has a complex mechanism of action that involve alterations in other glutamate receptors. The metabotropic glutamate receptor 5 (mGluR5) has been investigated in relation to the psychotic and anesthetic properties of ketamine, while its role in mediating the...

Synergistic use of deep TMS therapy with IV ketamine infusions for major depressive disorder: a pilot study.

Psychopharmacology July 1, 2024 Nathaniel A. Shanok, Sabrina Muzac, Leah Brown et al. 7 citations

Major Depressive Disorder (MDD) is a pervasive psychiatric condition effecting approximately 21 million adults in the U.S. (8.4%). An estimated 30-60% of patients are resistant to traditional treatment approaches (medications and talk-therapy), alluding to the need for additional options. Two promising treatment modalities include transcranial magnetic stimulation (TMS) and ketamine infusions;...

Implementation of a ketamine programme for treatment-resistant depression in the public health system: Lessons from the first Australian public hospital clinic.

Australian & New Zealand Journal of Psychiatry July 1, 2024 Nicollette Lr Thornton, Dean J Wright, Nick Glozier 5 citations

One could argue that we are living through a period of innovation and change in psychiatry unlike that seen before, with repurposed medications emerging as novel treatments. However, despite evidence of enhanced clinical outcomes and potential medium-term savings, delivering these promising interventions is resource-intensive and perceived as difficult in the public sector. Consequently, they...

DOI: 10.1177/00048674241237094 (opens in new tab) Full text (opens in new tab) Implementation Public hospital Ketamine therapy Mental health treatment +3

Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis.

Journal of Affective Disorders July 1, 2024 Ashok Seshadri, Larry J. Prokop, Balwinder Singh 50 citations

Intravenous (IV) racemic ketamine and intranasal (IN) esketamine have demonstrated rapid antidepressant effects in treatment-resistant depression (TRD). This systematic review aims to evaluate the efficacy and safety of ketamine and esketamine at various dosages for depression. We included randomized controlled trials (RCTs) with parallel group dose comparison of ketamine and esketamine for...

Fixed dose ketamine for prehospital management of hyperactive delirium with severe agitation.

The American Journal of Emergency Medicine July 1, 2024 Michael C O'Brien, Kyle J Kelleran, Susan J Burnett et al. 6 citations

Patients exhibiting signs of hyperactive delirium with severe agitation (HDSA) may require sedating medications for stabilization and safe transport to the hospital. Determining the patient's weight and calculating the correct weight-based dose may be challenging in an emergency. A fixed dose ketamine protocol is an alternative to the traditional weight-based administration, which may also...

DOI: 10.1016/j.ajem.2024.04.011 (opens in new tab) Full text (opens in new tab) Hyperactive delirium Prehospital care Weight-based dose #ketamine_sedation ketamine +7

Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis.

Journal of Affective Disorders July 1, 2024 Cameron N Calder, Angela T H Kwan, Kayla M Teopiz et al. 31 citations

Ketamine has been established as efficacious in adults living with Treatment-resistant Depression (TRD). Toward providing a quantifiable estimate of the clinical meaningfulness of the therapeutic benefit of ketamine, herein, we conduct a systematic review that aims to report the Number Needed to Treat (NNT) and the Number Needed to Harm (NNH). This systematic review searched Embase,...

Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study.

Psychiatry Research July 1, 2024 Ana Paula Anzolin, Daniel Prates Baldez, Bruno Braga Montezano et al. 2 citations

This investigation explores the efficacy of subcutaneous ketamine for mitigating depressive symptoms and suicidal ideation, addressing a crucial need for rapid-onset treatments in severe depression cases. It introduces an innovative approach to administering an NMDA receptor antagonist, significantly advancing psychopharmacological methods for treating suicidal behaviors as distinct entities,...

DOI: 10.1016/j.psychres.2024.115915 (opens in new tab) Full text (opens in new tab) C-ssrs Suicidal ideation Mental health treatment Depression therapy +3

Exploring the impact of music on response to ketamine/esketamine: A scoping review.

Neuroscience & Biobehavioral Reviews July 1, 2024 Mina Kheirkhah, Allison C. Nugent, Alicia A Livinski et al. 13 citations

Music and ketamine are both known to affect therapeutic outcomes, but few studies have investigated their co-administration. This scoping review describes the existing literature on the joint use of music and ketamine-or esketamine (the S(+) enantiomer of ketamine)-in humans. The review considers that extant studies have explored the intersection of ketamine/esketamine and music in healthy...

DOI: 10.1016/j.neubiorev.2024.105693 (opens in new tab) Full text (opens in new tab) Esketamine Anesthesia Ketamine-assisted therapy Music intervention +2